[Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
The effect of Ca-antagonist, long-acting verapamil and the selective beta-1 blocking bisoprolol were investigated and compared in the secondary prevention after myocardial infarction. Eighty-seven patients were enrolled, 27 patients were not included because of the exclusion criteria, 30 patients were treated with verapamil and 30 patients with bisoprolol. During the 540 days of follow up period treadmill ergometry and dobutamine stress-test with SPECT investigation were performed two times. Both clinically and the data of our investigations the effect of the two drugs in the secondary prevention was good, and even at the 540th day the protective effect was still excellent.
Sárosi
I
I
Pécsi Orvostudományi Egyetem, Pécs Anaesthesiologiai és Intenzív Therapiás Intézet.
Debreceni
G
G
Mühl
D
D
Kónyi
A
A
Bogár
L
L
Tekeres
M
M
Tóth
K
K
Habon
T
T
Czopf
L
L
Zámbó
K
K
Schmidt
E
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control*; D014700:Verapamil / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D014700:Verapamil; D017298:Bisoprolol